Last 12 months
Inside the activity.
0 purchase rows · 7 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 30, 2026 Filed Apr 1, 2026 21:20 UTC |
Shvartsburg AlexChief Financial Officer
|
Exercise / conversionPerformance Stock Units · Derivative | 5,768 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-26-000025 · wk-form4_1775078415.xml · derivative · entry 7 Shvartsburg Alex · CIK 0001830830 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 5,768 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each PSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement. F9 · derivative.exercise_date: On March 30, 2023, reporting person was granted PSUs to vest or lapse on March 30, 2026 based on the Company's cumulative free cash flow (FCF) for performance period 2023-2025 compared to a target determined by the 2022 Plan Administrator. The Company has determined that 122.0% of the underlying PSUs shall vest on March 30, 2026, subject to continued service during the vesting period and the award agreement. The performance achieved was 122.0%, and the actual number of vested shares is presented as the quantity that was acquired. F9 · derivative.expiration_date: On March 30, 2023, reporting person was granted PSUs to vest or lapse on March 30, 2026 based on the Company's cumulative free cash flow (FCF) for performance period 2023-2025 compared to a target determined by the 2022 Plan Administrator. The Company has determined that 122.0% of the underlying PSUs shall vest on March 30, 2026, subject to continued service during the vesting period and the award agreement. The performance achieved was 122.0%, and the actual number of vested shares is presented as the quantity that was acquired. Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 21:20 UTC |
Shvartsburg AlexChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,621 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-26-000025 · wk-form4_1775078415.xml · derivative · entry 6 Shvartsburg Alex · CIK 0001830830 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,240 Underlying: Ordinary Shares · 3,621 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement. F7 · derivative.exercise_date: On March 30, 2025, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the First Amended and Restated LivaNova PLC 2022 Incentive Award Plan (the First A&R 2022 Plan) and the award agreement. F7 · derivative.expiration_date: On March 30, 2025, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the First Amended and Restated LivaNova PLC 2022 Incentive Award Plan (the First A&R 2022 Plan) and the award agreement. Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 21:20 UTC |
Shvartsburg AlexChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,787 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-26-000025 · wk-form4_1775078415.xml · derivative · entry 5 Shvartsburg Alex · CIK 0001830830 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,575 Underlying: Ordinary Shares · 1,787 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement. F6 · derivative.exercise_date: On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement. F6 · derivative.expiration_date: On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement. Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 21:20 UTC |
Shvartsburg AlexChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,364 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-26-000025 · wk-form4_1775078415.xml · derivative · entry 4 Shvartsburg Alex · CIK 0001830830 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,364 Underlying: Ordinary Shares · 2,364 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement. F5 · derivative.exercise_date: On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Company's 2022 Incentive Award Plan (the 2022 Plan) and the award agreement. F5 · derivative.expiration_date: On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Company's 2022 Incentive Award Plan (the 2022 Plan) and the award agreement. Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 21:20 UTC |
Shvartsburg AlexChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 914 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-26-000025 · wk-form4_1775078415.xml · derivative · entry 3 Shvartsburg Alex · CIK 0001830830 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 914 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement. F4 · derivative.exercise_date: On March 30, 2022, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2023. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the award agreement. F4 · derivative.expiration_date: On March 30, 2022, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2023. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the award agreement. Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 21:20 UTC |
Shvartsburg AlexChief Financial Officer
|
Tax withholdingOrdinary Shares | 12,868 | $61.27 | $788,422.36 |
DisclosureSEC source: 0001639691-26-000025 · wk-form4_1775078415.xml · nonDerivative · entry 2 Shvartsburg Alex · CIK 0001830830 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,647 F2 · shares: Shares withheld to satisfy tax liability. Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 21:20 UTC |
Shvartsburg AlexChief Financial Officer
|
Exercise / conversionOrdinary Shares | 30,835 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-26-000025 · wk-form4_1775078415.xml · nonDerivative · entry 1 Shvartsburg Alex · CIK 0001830830 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,515 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reporting person had vested restricted stock units (RSUs) and vested performance stock units (PSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 17:25 UTC |
Poletti FrancoPresident, Cardiopulmonary
|
Exercise / conversionStock Appreciation Rights · Derivative | 2,140 | $0.00 Strike: $57.60 | $0.00 |
DisclosureSEC source: 0001639691-26-000015 · wk-form4_1773437128.xml · derivative · entry 5 Poletti Franco · CIK 0002031281 · President, Cardiopulmonary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,140 shares Expires 2026-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Reporting person was granted SARs on March 11, 2016 that vested in four equal annual installments beginning March 11, 2017 under the LivaNova PLC 2015 Incentive Award Plan and were automatically exercised upon their March 11, 2026 expiration date. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 17:25 UTC |
Poletti FrancoPresident, Cardiopulmonary
|
Tax withholdingOrdinary Shares | 69 | $62.26 | $4,295.94 |
DisclosureSEC source: 0001639691-26-000015 · wk-form4_1773437128.xml · nonDerivative · entry 3 Poletti Franco · CIK 0002031281 · President, Cardiopulmonary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,941 F2 · shares: Shares withheld to satisfy tax liability. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 17:25 UTC |
Poletti FrancoPresident, Cardiopulmonary
|
Tax withholdingOrdinary Shares | 1,980 | $62.26 | $123,274.80 |
DisclosureSEC source: 0001639691-26-000015 · wk-form4_1773437128.xml · nonDerivative · entry 2 Poletti Franco · CIK 0002031281 · President, Cardiopulmonary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,010 F1 · shares: Shares withheld for stock appreciation right ("SAR") base price settlement. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 17:25 UTC |
Poletti FrancoPresident, Cardiopulmonary
|
Exercise / conversionOrdinary Shares | 2,140 | $57.60 | $123,264.00 |
DisclosureSEC source: 0001639691-26-000015 · wk-form4_1773437128.xml · nonDerivative · entry 1 Poletti Franco · CIK 0002031281 · President, Cardiopulmonary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,990 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 16:06 UTC |
Poletti FrancoPresident, Cardiopulmonary
|
Exercise / conversionRestricted Stock Units · Derivative | 967 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000163 · wk-form4_1766005586.xml · derivative · entry 4 Poletti Franco · CIK 0002031281 · President, Cardiopulmonary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 967 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Amended and Restated LivaNova PLC 2022 Incentive Award Plan (the "Plan") and the award agreement. F4 · derivative.exercise_date: On December 15, 2023, reporting person was granted RSUs subject to a two-year vesting schedule, the final vesting for which occurred on December 15, 2025. The RSUs were subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. F4 · derivative.expiration_date: On December 15, 2023, reporting person was granted RSUs subject to a two-year vesting schedule, the final vesting for which occurred on December 15, 2025. The RSUs were subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 16:06 UTC |
Poletti FrancoPresident, Cardiopulmonary
|
Tax withholdingOrdinary Shares | 416 | $63.06 | $26,232.96 |
DisclosureSEC source: 0001639691-25-000163 · wk-form4_1766005586.xml · nonDerivative · entry 2 Poletti Franco · CIK 0002031281 · President, Cardiopulmonary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,850 F2 · shares: Shares withheld to satisfy tax liability. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 16:06 UTC |
Poletti FrancoPresident, Cardiopulmonary
|
Exercise / conversionOrdinary Shares | 967 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000163 · wk-form4_1766005586.xml · nonDerivative · entry 1 Poletti Franco · CIK 0002031281 · President, Cardiopulmonary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,266 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reporting person had vested restricted stock units ("RSUs") settled in ordinary shares of LivaNova PLC (the "Company"), GBP 1.00 par value. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:06 UTC |
PODLOGAR SUSAN MDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 2,355 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000162 · wk-form4_1766005580.xml · derivative · entry 3 PODLOGAR SUSAN M · CIK 0001709959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,355 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the "Plan") and the award agreement. F4 · derivative.exercise_date: On December 15, 2024, reporting person was granted RSUs subject to a one-year vesting schedule, which occurred on December 15, 2025. The RSUs were subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. F4 · derivative.expiration_date: On December 15, 2024, reporting person was granted RSUs subject to a one-year vesting schedule, which occurred on December 15, 2025. The RSUs were subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:06 UTC |
PODLOGAR SUSAN MDirector
|
Tax withholdingOrdinary Shares | 269 | $63.06 | $16,963.14 |
DisclosureSEC source: 0001639691-25-000162 · wk-form4_1766005580.xml · nonDerivative · entry 2 PODLOGAR SUSAN M · CIK 0001709959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,086 F2 · shares: Shares withheld to satisfy tax liability. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:06 UTC |
PODLOGAR SUSAN MDirector
|
Exercise / conversionOrdinary Shares | 2,355 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000162 · wk-form4_1766005580.xml · nonDerivative · entry 1 PODLOGAR SUSAN M · CIK 0001709959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,355 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reporting person had vested restricted stock units ("RSUs") settled in ordinary shares of LivaNova PLC (the "Company"), GBP 1.00 par value. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 16:06 UTC |
Hutchinson Michael DamonSVP, CLO and Company Secretary
|
Exercise / conversionRestricted Stock Units · Derivative | 2,254 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000161 · wk-form4_1766005572.xml · derivative · entry 3 Hutchinson Michael Damon · CIK 0001606626 · SVP, CLO and Company Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,253 Underlying: Ordinary Shares · 2,254 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2022 Incentive Award Plan (the "Plan") and the award agreement. F4 · derivative.exercise_date: On December 15, 2022, reporting person was granted RSUs subject to a four-year vesting schedule, the third vesting for which occurred on December 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. F4 · derivative.expiration_date: On December 15, 2022, reporting person was granted RSUs subject to a four-year vesting schedule, the third vesting for which occurred on December 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 16:06 UTC |
Hutchinson Michael DamonSVP, CLO and Company Secretary
|
Tax withholdingOrdinary Shares | 1,122 | $63.06 | $70,753.32 |
DisclosureSEC source: 0001639691-25-000161 · wk-form4_1766005572.xml · nonDerivative · entry 2 Hutchinson Michael Damon · CIK 0001606626 · SVP, CLO and Company Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,798 F2 · shares: Shares withheld to satisfy tax liability. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 16:06 UTC |
Hutchinson Michael DamonSVP, CLO and Company Secretary
|
Exercise / conversionOrdinary Shares | 2,254 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000161 · wk-form4_1766005572.xml · nonDerivative · entry 1 Hutchinson Michael Damon · CIK 0001606626 · SVP, CLO and Company Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,920 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reporting person had vested restricted stock units ("RSUs") settled in ordinary shares of LivaNova PLC (the "Company"), GBP 1.00 par value. Read SEC document |
| November 18, 2025 Filed Nov 19, 2025 20:57 UTC |
Story BrookeDirector
|
SaleOrdinary Shares | 250 | $53.94 | $13,485.00 |
DisclosureSEC source: 0001639691-25-000154 · wk-form4_1763585818.xml · nonDerivative · entry 1 Story Brooke · CIK 0001866136 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,232 Read SEC document |
| September 15, 2025 Filed Sep 17, 2025 16:05 UTC |
Poletti FrancoPresident, Cardiopulmonary
|
Exercise / conversionRestricted Stock Units · Derivative | 643 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000135 · wk-form4_1758139532.xml · derivative · entry 4 Poletti Franco · CIK 0002031281 · President, Cardiopulmonary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,932 Underlying: Ordinary Shares · 643 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the "Plan") and the award agreement. F4 · derivative.exercise_date: On September 15, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments. The first vesting occurred on September 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. F4 · derivative.expiration_date: On September 15, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments. The first vesting occurred on September 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. Read SEC document |
| September 15, 2025 Filed Sep 17, 2025 16:05 UTC |
Poletti FrancoPresident, Cardiopulmonary
|
Tax withholdingOrdinary Shares | 277 | $55.43 | $15,354.11 |
DisclosureSEC source: 0001639691-25-000135 · wk-form4_1758139532.xml · nonDerivative · entry 2 Poletti Franco · CIK 0002031281 · President, Cardiopulmonary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,299 F2 · shares: Shares withheld to satisfy tax liability. Read SEC document |
| September 15, 2025 Filed Sep 17, 2025 16:05 UTC |
Poletti FrancoPresident, Cardiopulmonary
|
Exercise / conversionOrdinary Shares | 643 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000135 · wk-form4_1758139532.xml · nonDerivative · entry 1 Poletti Franco · CIK 0002031281 · President, Cardiopulmonary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,576 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reporting person had vested restricted stock units ("RSUs") settled in ordinary shares of LivaNova PLC (the "Company"), GBP 1.00 par value. Read SEC document |
| September 15, 2025 Filed Sep 17, 2025 20:08 UTC |
Zurbay DonaldDirector
|
GrantRestricted Stock Units · Derivative | 2,560 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000137 · wk-form4_1758139698.xml · derivative · entry 1 Zurbay Donald · CIK 0001341608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,560 Underlying: Ordinary Shares · 2,560 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2025 Director Incentive Award Plan (the "Plan") and the award agreement. F2 · derivative.exercise_date: On September 15, 2025, reporting person was granted RSUs to vest and forfeiture restrictions thereon to lapse on June 15, 2026, subject to continued service during the vesting period and the award agreement. F2 · derivative.expiration_date: On September 15, 2025, reporting person was granted RSUs to vest and forfeiture restrictions thereon to lapse on June 15, 2026, subject to continued service during the vesting period and the award agreement. Read SEC document |
| August 25, 2025 Filed Aug 27, 2025 20:17 UTC |
Bianchi FrancescoDirector
|
SaleOrdinary Shares | 1,500 | $56.50 | $84,750.00 |
DisclosureSEC source: 0001639691-25-000110 · wk-form4_1756325830.xml · nonDerivative · entry 1 Bianchi Francesco · CIK 0001656080 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,028 Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:53 UTC |
Tezel AhmetChief Innovation Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000076 · wk-form4_1750193624.xml · derivative · entry 3 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,896 Underlying: Ordinary Shares · 2,967 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the Plan) and the award agreement. F4 · derivative.exercise_date: On June 15, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on June 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. F4 · derivative.expiration_date: On June 15, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on June 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:53 UTC |
Tezel AhmetChief Innovation Officer
|
Tax withholdingOrdinary Shares | 1,032 | $45.76 | $47,224.32 |
DisclosureSEC source: 0001639691-25-000076 · wk-form4_1750193624.xml · nonDerivative · entry 2 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,935 F3 · shares: Shares withheld to satisfy tax liability. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:53 UTC |
Tezel AhmetChief Innovation Officer
|
Exercise / conversionOrdinary Shares | 2,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000076 · wk-form4_1750193624.xml · nonDerivative · entry 1 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,967 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), 1.00 GBP par value. F2 · price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the Plan) and the award agreement. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:54 UTC |
Story BrookeDirector
|
GrantRestricted Stock Units · Derivative | 4,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000079 · wk-form4_1750193653.xml · derivative · entry 4 Story Brooke · CIK 0001866136 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,042 Underlying: Ordinary Shares · 4,042 shares Expires not disclosed F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement. F6 · derivative.exercise_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2026, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement. F6 · derivative.expiration_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2026, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:54 UTC |
Story BrookeDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000079 · wk-form4_1750193653.xml · derivative · entry 3 Story Brooke · CIK 0001866136 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,416 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the 2015 Plan award agreement. F4 · derivative.exercise_date: RSUs granted under the 2015 Plan on June 15, 2024 that vested on June 15, 2025. F4 · derivative.expiration_date: RSUs granted under the 2015 Plan on June 15, 2024 that vested on June 15, 2025. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:54 UTC |
Story BrookeDirector
|
Tax withholdingOrdinary Shares | 410 | $45.76 | $18,761.60 |
DisclosureSEC source: 0001639691-25-000079 · wk-form4_1750193653.xml · nonDerivative · entry 2 Story Brooke · CIK 0001866136 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,482 F3 · shares: Shares withheld to satisfy tax liability. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:54 UTC |
Story BrookeDirector
|
Exercise / conversionOrdinary Shares | 3,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000079 · wk-form4_1750193653.xml · nonDerivative · entry 1 Story Brooke · CIK 0001866136 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,892 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), 1.00 GBP par value. F2 · price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the 2015 Plan award agreement. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:54 UTC |
Barry James ChristopherDirector
|
GrantRestricted Stock Units · Derivative | 4,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000080 · wk-form4_1750193664.xml · derivative · entry 4 Barry James Christopher · CIK 0001756949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,042 Underlying: Ordinary Shares · 4,042 shares Expires not disclosed F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement. F6 · derivative.exercise_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2026, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement. F6 · derivative.expiration_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2026, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:54 UTC |
Barry James ChristopherDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000080 · wk-form4_1750193664.xml · derivative · entry 3 Barry James Christopher · CIK 0001756949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,416 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the 2015 Plan award agreement. F4 · derivative.exercise_date: RSUs granted under the 2015 Plan on June 15, 2024 that vested on June 15, 2025. F4 · derivative.expiration_date: RSUs granted under the 2015 Plan on June 15, 2024 that vested on June 15, 2025. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:54 UTC |
Barry James ChristopherDirector
|
Tax withholdingOrdinary Shares | 410 | $45.76 | $18,761.60 |
DisclosureSEC source: 0001639691-25-000080 · wk-form4_1750193664.xml · nonDerivative · entry 2 Barry James Christopher · CIK 0001756949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,362 F3 · shares: Shares withheld to satisfy tax liability. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:54 UTC |
Barry James ChristopherDirector
|
Exercise / conversionOrdinary Shares | 3,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000080 · wk-form4_1750193664.xml · nonDerivative · entry 1 Barry James Christopher · CIK 0001756949 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,772 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), 1.00 GBP par value. F2 · price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the 2015 Plan award agreement. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:53 UTC |
PODLOGAR SUSAN MDirector
|
GrantRestricted Stock Units · Derivative | 4,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000075 · wk-form4_1750193614.xml · derivative · entry 1 PODLOGAR SUSAN M · CIK 0001709959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,042 Underlying: Ordinary Shares · 4,042 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement. F2 · derivative.exercise_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2026, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement. F2 · derivative.expiration_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2026, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:54 UTC |
WILVER PETER MDirector
|
GrantRestricted Stock Units · Derivative | 4,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000077 · wk-form4_1750193633.xml · derivative · entry 4 WILVER PETER M · CIK 0001234537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,042 Underlying: Ordinary Shares · 4,042 shares Expires not disclosed F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement. F6 · derivative.exercise_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2026, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement. F6 · derivative.expiration_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2026, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:54 UTC |
WILVER PETER MDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000077 · wk-form4_1750193633.xml · derivative · entry 3 WILVER PETER M · CIK 0001234537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,416 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the 2015 Plan award agreement. F4 · derivative.exercise_date: RSUs granted under the 2015 Plan on June 15, 2024 that vested on June 15, 2025. F4 · derivative.expiration_date: RSUs granted under the 2015 Plan on June 15, 2024 that vested on June 15, 2025. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:54 UTC |
WILVER PETER MDirector
|
Tax withholdingOrdinary Shares | 410 | $45.76 | $18,761.60 |
DisclosureSEC source: 0001639691-25-000077 · wk-form4_1750193633.xml · nonDerivative · entry 2 WILVER PETER M · CIK 0001234537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,738 F3 · shares: Shares withheld to satisfy tax liability. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:54 UTC |
WILVER PETER MDirector
|
Exercise / conversionOrdinary Shares | 3,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000077 · wk-form4_1750193633.xml · nonDerivative · entry 1 WILVER PETER M · CIK 0001234537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,148 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), 1.00 GBP par value. F2 · price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the 2015 Plan award agreement. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:54 UTC |
KOZY WILLIAM ADirector
|
GrantRestricted Stock Units · Derivative | 5,681 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000081 · wk-form4_1750193673.xml · derivative · entry 4 KOZY WILLIAM A · CIK 0001221785 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,681 Underlying: Ordinary Shares · 5,681 shares Expires not disclosed F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement. F6 · derivative.exercise_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2026, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement. F6 · derivative.expiration_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2026, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:54 UTC |
KOZY WILLIAM ADirector
|
Exercise / conversionRestricted Stock Units · Derivative | 4,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000081 · wk-form4_1750193673.xml · derivative · entry 3 KOZY WILLIAM A · CIK 0001221785 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,840 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the 2015 Plan award agreement. F4 · derivative.exercise_date: RSUs granted under the 2015 Plan on June 15, 2024 that vested on June 15, 2025. F4 · derivative.expiration_date: RSUs granted under the 2015 Plan on June 15, 2024 that vested on June 15, 2025. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:54 UTC |
KOZY WILLIAM ADirector
|
Tax withholdingOrdinary Shares | 581 | $45.76 | $26,586.56 |
DisclosureSEC source: 0001639691-25-000081 · wk-form4_1750193673.xml · nonDerivative · entry 2 KOZY WILLIAM A · CIK 0001221785 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,567 F3 · shares: Shares withheld to satisfy tax liability. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:54 UTC |
KOZY WILLIAM ADirector
|
Exercise / conversionOrdinary Shares | 4,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000081 · wk-form4_1750193673.xml · nonDerivative · entry 1 KOZY WILLIAM A · CIK 0001221785 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,148 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), 1.00 GBP par value. F2 · price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the 2015 Plan award agreement. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:54 UTC |
SCHERMERHORN TODD CDirector
|
GrantRestricted Stock Units · Derivative | 4,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000082 · wk-form4_1750193683.xml · derivative · entry 4 SCHERMERHORN TODD C · CIK 0001204654 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,042 Underlying: Ordinary Shares · 4,042 shares Expires not disclosed F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement. F6 · derivative.exercise_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2026, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement. F6 · derivative.expiration_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2026, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:54 UTC |
SCHERMERHORN TODD CDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000082 · wk-form4_1750193683.xml · derivative · entry 3 SCHERMERHORN TODD C · CIK 0001204654 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,416 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the 2015 Plan award agreement. F4 · derivative.exercise_date: RSUs granted under the 2015 Plan on June 15, 2024 that vested on June 15, 2025. F4 · derivative.expiration_date: RSUs granted under the 2015 Plan on June 15, 2024 that vested on June 15, 2025. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:54 UTC |
SCHERMERHORN TODD CDirector
|
Tax withholdingOrdinary Shares | 410 | $45.76 | $18,761.60 |
DisclosureSEC source: 0001639691-25-000082 · wk-form4_1750193683.xml · nonDerivative · entry 2 SCHERMERHORN TODD C · CIK 0001204654 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,063 F3 · shares: Shares withheld to satisfy tax liability. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:54 UTC |
SCHERMERHORN TODD CDirector
|
Exercise / conversionOrdinary Shares | 3,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000082 · wk-form4_1750193683.xml · nonDerivative · entry 1 SCHERMERHORN TODD C · CIK 0001204654 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,473 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), 1.00 GBP par value. F2 · price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the 2015 Plan award agreement. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.